ENHERTU is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-positive breast cancer that cannot be removed by surgery or that has …

ENHERTU is given 1 time every three weeks (21-day treatment cycle). Your healthcare provider will decide how many treatments you need. Your healthcare provider will give you medicines …

ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have: HER2-low breast cancer that cannot be removed by surgery or that has spread to other parts of your …

ENHERTU is a prescription medicine used to treat adults who have: Human epidermal growth factor receptor 2 (HER2)-low breast cancer that cannot be removed by surgery or that has …

Find information about HER2-positive mBC, how ENHERTU® (fam-trastuzumab deruxtecan-nxki) is thought to work, and how you will receive it. See the full Important Safety Information, …

Understanding the ENHERTU® (fam-trastuzumab deruxtecan-nxki) clinical trial results. See the full Important Safety Information, Prescribing Information, including Boxed WARNINGS, and …

Find information about ENHERTU® (fam-trastuzumab deruxtecan-nxki), including clinical trial results, safety information, downloadable resources, and more. See Full Safety, Boxed …

ENHERTU (en-HER-too) is a prescription medicine used to treat adults who have: Stomach cancer called gastric or gastroesophageal junction (GEJ) adenocarcinoma that is HER2 …

ENHERTU is a prescription medicine used to treat adults who have: HER2-low breast cancer that cannot be removed by surgery or that has spread to other parts of the body (metastatic), and …

ENHERTU is given 1 time every three weeks (21-day treatment cycle). Your healthcare provider will decide how many treatments you need. Your healthcare provider will give you medicines …